COPD – Update to the Treatable Traits Paradigm for Managed Care

Webinar Recorded on Sept. 30, 2020 
Sponsored by GSK  

With total medical costs of nearly $50 billion, chronic obstructive pulmonary disease (COPD) is a treatable disease with two specific treatable traits from GOLD,* symptoms and exacerbations, which may impact various areas of disease burden.

This program updates the previous treatable traits webinar, COPD – Simplifying a Complex Treatment Paradigm for Managed Care, to guide pharmacotherapy to lessen the symptom burden and decrease risk of future exacerbations.

In addition to reviewing the treatable traits from GOLD, this updated program discusses:

• The new American Thoracic Society guidelines 
• The new COPD Foundation algorithm, and
• Updated case studies

This updated review, incorporating various COPD organization recommendations, can further help managed care professionals ensure appropriate access to evidence-based approaches that allow HCPs to better diagnose patients and select optimal therapy.

*Global Initiative for Chronic Obstructive Lung Disease

Speaker:

• Marjorie Podraza Stiegler, MD
  Adjunct Associate Professor
  University of North Carolina at Chapel Hill School of Medicine
  Medical Director, Respiratory Therapeutic Area
  US Medical Affairs, GSK

This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP. 

Sponsored by: